Reproductive Assessment Lab Profile ch.72 assessment of the reproductive system. Flashcards
Luteinizing Hormone (lutropin)
Man: 1.24–7.8 IU/L
Women: follicular phase, 1.68-15 IU/L midcycle, 21.9–56.6 IU/L; luteal phase, 0.61–16.3 IU/L; post menopause, 14.2-52.3 IU/L
Decreased levels indicate possible infertility, anovulation
Elevations indicate possible ovarian failure, Turner’s syndrome
Follicle stimulating Hormone (follitropin)
Men; 1.42–15.4 IU/L
Women; follicular phase, 1.37–9.9 IU/L
Midcycle, 6.17–17.2 IU/L; luteal phase, 1.09–9.2 IU/L; post menopause, 19.3 - 100.6 IU/L
Decreased levels indicate possible and fertility, anorexia nervosa, neoplasm
Elevations indicate possible to Turner’s syndrome
Prolactin
Men: 0–20 ng/mL
Women: 0–20 ng/mL
Pregnant women: 20-400/mL
Elevations indicate possible galactorrhea (breast discharge), pituitary tumor, disease of hypothalamus or pituitary gland, hyperthyroidism
Estradiol
Man: 10–50 pg/mL
Women: follicular phase: 20-350 pg/mL; midcycle, 150-750 pg/mL; luteal phase, 30-450 pg/mL; post menopause, <or equal to 20 pg/mL
Elevations of estradiol, Total estrogens, and estriol in men indicate possible gynecomastica, decreased body hair , increased fat deposits, feminization, testicular tumor; and women, ovarian tumor
Estriol
Men and nonpregnant women: <2.0 ng/dL
Decrease levels of estradiol, total estrogens, and estriol into women indicate possible amenorrhea, climacteric, and impending miscarriage, hypothalamic disorders
Progesterone
Man: 10 – 15 ng/dL
Women: follicular phase, <40 ng/dL
Decreased levels in women indicate possible inadequate luteal phase, amenorrhea
Elevations in women indicate possible ovarian luteal cysts
Decreased levels may indicate ovarian neoplasm, ovarian dysfunction
Testosterone
Man: 280–1080 ng/dL
Women: < 70 ng/dL
Increased levels in that indicate possible testicular tumor, hyperthyroidism
Decreased levels in men indicate possible hypogonadism
Elevations and women indicate possible adrenal neoplasm, ovarian neoplasm, polycystic ovary syndrome
